We are live on ! Find out more
PG

Pendal Group Portfolio holdings

AUM $11.6B
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS Inc
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZIP icon
276
ZipRecruiter
ZIP
$339M
$1.43M 0.01%
+51,651
New +$1.34M
GPC icon
277
Genuine Parts
GPC
$17.9B
$1.42M 0.01%
11,693
-16,749
-59% -$2.09M
EMWP
278
DELISTED
Eros Media World PLC
EMWP
$1.38M 0.01%
+75,228
New +$1.44M
MDT icon
279
Medtronic
MDT
$112B
$1.36M 0.01%
10,890
+2,675
+33% +$346K
BBWI icon
280
Bath & Body Works
BBWI
$3.97B
$1.36M 0.01%
21,626
+9,579
+80% +$609K
PG icon
281
Procter & Gamble
PG
$340B
$1.36M 0.01%
9,706
-23,007
-70% -$3.26M
PBA icon
282
Pembina Pipeline
PBA
$29.3B
$1.36M 0.01%
42,824
+36,478
+575% +$1.15M
ARMK icon
283
Aramark
ARMK
$15B
$1.35M 0.01%
57,077
-3,750,415
-99% -$92.8M
GLD icon
284
SPDR Gold Trust
GLD
$131B
$1.35M 0.01%
8,208
+56
+0.7% +$9.37K
IAU icon
285
iShares Gold Trust
IAU
$62.8B
$1.35M 0.01%
40,351
+275
+0.7% +$9.37K
OTEX icon
286
Open Text
OTEX
$6.28B
$1.34M 0.01%
27,435
-51,210
-65% -$2.67M
CMI icon
287
Cummins
CMI
$83.6B
$1.34M 0.01%
5,948
-172
-3% -$40.3K
ECC
288
Eagle Point Credit Company
ECC
$497M
$1.33M 0.01%
97,908
+7,141
+8% +$97K
COO icon
289
Cooper Companies
COO
$14.2B
$1.31M 0.01%
+12,680
New +$1.35M
MRVL icon
290
Marvell Technology
MRVL
$147B
$1.31M 0.01%
21,700
+315
+1% +$18.9K
HOLX
291
DELISTED
Hologic
HOLX
$1.3M 0.01%
17,628
+4,691
+36% +$352K
ABCL icon
292
AbCellera Biologics
ABCL
$1.65B
$1.3M 0.01%
+64,826
New +$1.15M
TRU icon
293
TransUnion
TRU
$16B
$1.27M 0.01%
11,288
-2,531
-18% -$298K
TRNO icon
294
Terreno Realty
TRNO
$7.58B
$1.26M 0.01%
19,900
+1,400
+8% +$93.2K
DHR icon
295
Danaher
DHR
$138B
$1.25M 0.01%
4,648
-21,707
-82% -$5.91M
WEX icon
296
WEX
WEX
$6.42B
$1.25M 0.01%
7,090
+78
+1% +$14.2K
ESRT icon
297
Empire State Realty Trust
ESRT
$1B
$1.23M 0.01%
122,300
+3,200
+3% +$34.5K
DEI icon
298
Douglas Emmett
DEI
$2.05B
$1.22M 0.01%
38,720
+707
+2% +$23.3K
QRVO icon
299
Qorvo
QRVO
$7.9B
$1.2M 0.01%
7,196
-1,501
-17% -$279K
CVS icon
300
CVS Health
CVS
$135B
$1.2M 0.01%
14,145
-25,858
-65% -$2.17M
10 11
12
13 14

Similar funds

RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.